ReviewFrontiers in cardiovascular medicine2021
Sphingolipid Profiling: A Promising Tool for Stratifying the Metabolic Syndrome-Associated Risk.
Loni Berkowitz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this paperpooled itcites it